Kolexia
Merle Patrick Pneumologie
Merle Patrick
Pneumologie
Hôpital Gabriel Montpied
Clermont-Ferrand, France
81 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Adénocarcinome Métastase tumorale Complications postopératoires Carcinome épidermoïde Carcinome à grandes cellules

Collaborateurs

Voir plus
Moro-Sibilot Denis
Moro-Sibilot Denis
Hôpital Nord Grenoble, La Tronche, France
Souquet Pierre Jean
Souquet Pierre Jean
Hôpital Lyon Sud, Pierre-Bénite, France
Jeannin Gaelle
Jeannin Gaelle
Hôpital Gabriel Montpied, Clermont-Ferrand, France
Janicot Henri
Janicot Henri
Hôpital Gabriel Montpied, Clermont-Ferrand, France

Industries

Voir plus
Sanofi
11 collaboration(s)
Dernière en 2023
Amgen
6 collaboration(s)
Dernière en 2023
BMS
3 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ROSIE: A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   06 mars 2024
Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer.
Bulletin du cancer   26 octobre 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung cancer (Amsterdam, Netherlands)   22 septembre 2023
LORLATU: Efficacy of Treatment Sequences in Patients With ALK and ROS-1 Positive Non-small Cell Lung Cancer Who Received Lorlatinib as Part of the French Expanded Access Program
Essai Clinique (Pfizer)   22 mai 2023
ADAPTABLE: A Non-comparative Randomized Phase II Trial Evaluating the Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced Non-squamous NSCLC Progressing After Immunotherapy and Chemotherapy
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   27 avril 2023
Perceived stress increases susceptibility to visual food cues in fast-food menu selections.
Physiology & behavior   24 avril 2023
Intérêt de la radiothérapie focale en cas d’oligroprogression sous immunothérapie dans le cadre du traitement de cancer bronchique non à petites cellules métastatique
27e Congrès de Pneumologie de Langue Française   01 janvier 2023
Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker.
Cancers   31 décembre 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
European journal of cancer (Oxford, England : 1990)   09 mars 2022
Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM EGFR V2 and NGS Technologies.
Molecular diagnosis & therapy   03 mars 2021